5-173234786-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000329198.5(NKX2-5):c.298C>A(p.Pro100Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000764 in 1,570,500 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P100A) has been classified as Likely benign.
Frequency
Consequence
ENST00000329198.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NKX2-5 | NM_004387.4 | c.298C>A | p.Pro100Thr | missense_variant | 1/2 | ENST00000329198.5 | NP_004378.1 | |
NKX2-5 | NM_001166176.2 | c.298C>A | p.Pro100Thr | missense_variant | 1/2 | NP_001159648.1 | ||
NKX2-5 | NM_001166175.2 | c.298C>A | p.Pro100Thr | missense_variant | 1/2 | NP_001159647.1 | ||
NKX2-5 | XM_017009071.3 | c.298C>A | p.Pro100Thr | missense_variant | 1/2 | XP_016864560.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NKX2-5 | ENST00000329198.5 | c.298C>A | p.Pro100Thr | missense_variant | 1/2 | 1 | NM_004387.4 | ENSP00000327758 | P1 | |
NKX2-5 | ENST00000424406.2 | c.298C>A | p.Pro100Thr | missense_variant | 1/2 | 1 | ENSP00000395378 | |||
NKX2-5 | ENST00000521848.1 | c.298C>A | p.Pro100Thr | missense_variant | 1/2 | 2 | ENSP00000427906 | |||
NKX2-5 | ENST00000517440.1 | c.298C>A | p.Pro100Thr | missense_variant | 1/2 | 4 | ENSP00000429905 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000145 AC: 3AN: 207084Hom.: 0 AF XY: 0.0000177 AC XY: 2AN XY: 112948
GnomAD4 exome AF: 0.00000776 AC: 11AN: 1418310Hom.: 0 Cov.: 31 AF XY: 0.0000114 AC XY: 8AN XY: 702480
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152190Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74350
ClinVar
Submissions by phenotype
Atrial septal defect 7 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 29, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 578303). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt NKX2-5 protein function. This variant has not been reported in the literature in individuals affected with NKX2-5-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.008%). This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 100 of the NKX2-5 protein (p.Pro100Thr). - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 27, 2024 | The p.P100T variant (also known as c.298C>A), located in coding exon 1 of the NKX2-5 gene, results from a C to A substitution at nucleotide position 298. The proline at codon 100 is replaced by threonine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at